ClinConnect ClinConnect Logo
Search / Trial NCT00389142

Identifying Genetic Causes of IC/BPS

Launched by BOSTON CHILDREN'S HOSPITAL · Oct 17, 2006

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Pelvic Pain Urinary Frequency Painful Bladder Urinary Urgency

ClinConnect Summary

This clinical trial is looking into the genetic causes of interstitial cystitis (IC), bladder pain syndrome (BPS), and chronic pelvic pain syndrome (CPPS). These conditions can cause ongoing pelvic pain and frequent urination, yet the exact reasons for them remain unclear. Researchers believe that genetics may play a role, as studies with twins and families suggest these conditions could be inherited. By collecting genetic samples and medical information from individuals and their families in North America, the trial aims to identify any genetic factors that might be linked to these painful conditions.

If you or a family member has been diagnosed with IC, BPS, or CPPS, you may be eligible to participate in this study. The trial is open to people of all ages, starting from 7 years old, and welcomes both males and females. To join, participants should have symptoms like frequent urination (more than once an hour), pelvic pain lasting three months or longer, or discomfort when urinating. Participants will provide genetic samples and medical history, and they may also include family members who do or do not have symptoms. This study is currently recruiting, and your involvement could help uncover important insights into these conditions, possibly leading to better treatments in the future.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Diagnosis of IC/BPS
  • Males and females of any age
  • Urinary frequency - more than 1X/hour, and/or
  • Dysuria, and/or
  • Pelvic, suprapubic, or abdominal pain - for 3 months or longer
  • Nocturia
  • Normal urinary stream (by history)
  • No evidence of active bacterial UTI (no pyuria \& negative urinary culture for last 3 months)
  • First degree relative of someone with above symptoms
  • Exclusion Criteria:
  • Major structural/anatomical urinary tract abnormalities by ultrasound
  • Underlying inborn conditions affecting the urinary tract
  • Surgery/chemotherapy affected pelvic area
  • GI or GU cancers
  • Severe Constipation in children only

About Boston Children's Hospital

Boston Children's Hospital is a leading pediatric healthcare institution renowned for its commitment to advancing child health through innovative research and exceptional clinical care. As a prominent clinical trial sponsor, the hospital leverages its extensive expertise in pediatric medicine to conduct rigorous and ethically sound research studies aimed at improving treatment options and outcomes for children. With a collaborative approach that integrates cutting-edge technology and multidisciplinary teams, Boston Children's Hospital is dedicated to translating scientific discoveries into practical applications that enhance the well-being of young patients and their families.

Locations

Boston, Massachusetts, United States

Patients applied

0 patients applied

Trial Officials

Catherine Brownstein, Ph.D.

Principal Investigator

Boston Children's Hosptial

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials